Close Menu

NEW YORK (GenomeWeb) – The Laboratory Corporation of America's Covance drug development business plans to offer single-cell DNA analysis services to its biopharmaceutical customers on Mission Bio's single-cell platform, Tapestri. In addition, the companies plan to evaluate the platform for the development of companion diagnostics, Mission Bio said on Thursday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.